Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MediWound Ltd. - Ordinary Shares
(NQ:
MDWD
)
14.18
-0.27 (-1.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MediWound Ltd. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
Next >
MediWound (MDWD) Q1 2025 Earnings Call Transcript
↗
May 21, 2025
Via
The Motley Fool
Topics
Earnings
MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 21, 2025
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Scheduled For May 21, 2025
↗
May 21, 2025
Via
Benzinga
Earnings Outlook For MediWound
↗
May 20, 2025
Via
Benzinga
Earnings Preview: MediWound
↗
November 25, 2024
Via
Benzinga
Earnings Scheduled For August 14, 2025
↗
August 14, 2025
Via
Benzinga
MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers
August 13, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report Second Quarter 2025 Financial Results
August 04, 2025
From
MediWound Ltd.
Via
GlobeNewswire
Accenture To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday
↗
May 22, 2025
Via
Benzinga
MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers
May 13, 2025
Post hoc analysis published in the peer-reviewed journal Wounds highlights EscharEx®’s superior clinical performance and comparable safety profile to SANTYL®
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Report First Quarter 2025 Financial Results
May 05, 2025
Conference call and webcast scheduled for Wednesday, May 21, 2025, at 8:30 a.m. Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
April 28, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 19, 2025
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Scheduled For March 19, 2025
↗
March 19, 2025
Via
Benzinga
MediWound to Report Fourth Quarter and Full Year 2024 Financial Results
March 03, 2025
Conference call and webcast scheduled for Wednesday, March 19th at 8:30 a.m. Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
↗
February 28, 2025
Via
Benzinga
MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care
February 25, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present at the 45th Annual TD Cowen Health Care Conference
February 24, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers
February 12, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 04, 2025
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
December 17, 2024
From
MediWound Ltd.
Via
GlobeNewswire
Urban Outfitters To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
November 27, 2024
Via
Benzinga
MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update
November 26, 2024
From
MediWound Ltd.
Via
GlobeNewswire
Earnings Scheduled For November 26, 2024
↗
November 26, 2024
Via
Benzinga
MediWound to Report Third Quarter 2024 Financial Results
November 12, 2024
Conference Call and Webcast Scheduled for Tuesday, November 26, 2024, at 8:30 a.m. Eastern Time
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers
October 10, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit
October 08, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 03, 2024
From
MediWound Ltd.
Via
GlobeNewswire
MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns
August 15, 2024
Approval Helps Solidify NexoBrid’s Position in the U.S. as a Safe and Effective Non-Surgical Burn Treatment for All Ages
From
MediWound Ltd.
Via
GlobeNewswire
MDWD Stock Earnings: MediWound Misses EPS, Beats Revenue for Q2 2024
↗
August 14, 2024
MDWD stock results show that MediWound missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
